ArticlePharmaceuticals (Basel, Switzerland)2021

Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use.

Sacha Zeerleder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.